The authors checked a subset of 909 participants against their medical records and found that participants tended to overstate their weight loss (5.79% measured vs 11.8% self-reported, median BMI change)
The MHRA Yellow Card scheme , which collects reports of suspected adverse drug reactions in the UK, has not highlighted memory loss as a significant safety concern for this medication class
IGF-1-LR3 IGF-1-LR3 (Long Arg3 IGF-1) is a modified variant of Insulin-like Growth Factor-1 with a much longer half-life and significantly reduced binding to binding proteins
If you have symptoms like fatigue, brain fog, or nerve pain plus suboptimal B12 levels, a trial of supplementation is worth trying since it's very safe
Monoamine Oxidase A Gene Polymorphisms and Enzyme Activity Associated with Risk of Gout in Taiwan Aborigines. Human Genetics, vol
Those who achieved good results on Semaglutide but wanted more may find Tirzepatide sufficient